Graves Light Lenhart Wealth, Inc. Novo Nordisk A S Transaction History

Graves Light Lenhart Wealth, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $5,031 - $6,023	-41 Reduced 2.6%	1,536 $219,000
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $38,495 - $51,241	-377 Reduced 19.29%	1,577 $202,000
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $171,522 - $206,049	1,954 New	1,954 $202,000
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $38,264 - $46,253	-411 Reduced 32.59%	850 $94,000
Q3 2021 Nov 15, 2021	SELL	$84.42 - $106.62 $7,006 - $8,849	-83 Reduced 6.18%	1,261 $121,000
Q2 2021 Jul 12, 2021	SELL	$67.66 - $84.76 $22,666 - $28,394	-335 Reduced 19.95%	1,344 $113,000
Q4 2020 Feb 04, 2021	BUY	$63.89 - $73.8 $107,271 - $123,910	1,679 New	1,679 $117,000

1,952

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $232B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Graves Light Lenhart Wealth, Inc., based on Form 13F filings with the SEC.

Stay updated on Graves Light Lenhart Wealth, Inc. with notifications on news.